• Atorvastatin: Mechanistic Leverage for Translational Discove

  2026-06-26

  This thought-leadership article provides translational researchers with a deep mechanistic exploration of Atorvastatin, a leading HMG-CoA reductase inhibitor, emphasizing its evolving role in cholesterol metabolism, vascular biology, and precision oncology. Integrating recent evidence—especially its ferroptosis-inducing effects in hepatocellular carcinoma (HCC)—the piece offers actionable strategic guidance, protocol detail, and a forward-looking perspective on workflow optimization with APExBIO’s Atorvastatin (SKU C6405).

• Trichostatin A (TSA): Epigenetic Control and Ferroptosis Ins

  2026-06-26

  Explore how Trichostatin A (TSA) advances epigenetic regulation in cancer research through HDAC inhibition, with a unique focus on its interplay with ferroptosis and mitochondrial metabolism. This in-depth analysis goes beyond standard protocols to inform next-generation experimental strategies.

• STING-Mediated dsDNA Sensing Triggers Antiviral Immunity in

  2026-06-25

  This study demonstrates that the STING protein in the marine invertebrate Litopenaeus vannamei directly senses viral double-stranded DNA, activating an interferon-like antiviral response. These findings illuminate the evolutionary origins of DNA-sensing pathways and provide a comparative foundation for innate immunity research across species.

• Carboplatin in Preclinical Oncology: Metabolic Vulnerabiliti

  2026-06-25

  Explore how Carboplatin, a platinum-based DNA synthesis inhibitor, reveals new metabolic vulnerabilities in cancer research. This article uniquely connects recent insights in oxidative phosphorylation with advanced experimental strategies for targeting tumor proliferation.

• Rapid Glucocorticoid Modulation of CaV1.2 via Kv2.1 in Hippo

  2026-06-24

  This study uncovers a rapid, nongenomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signaling in hippocampal neurons through the endocytosis of Kv2.1 channel clusters and downregulation of PKA activity. These findings provide new insight into how stress hormones dynamically influence neuronal excitability and highlight experimental strategies for dissecting cAMP/PKA signaling pathways.

• KNUCKLES Regulates Floral Meristem Termination via Hormone M

  2026-06-23

  This study reveals how the transcriptional repressor KNUCKLES (KNU) integrates auxin distribution and cytokinin activity to ensure the timely termination of the floral meristem in Arabidopsis. By uncovering direct repression of key hormonal genes at the chromatin level, the work provides a molecular framework that advances understanding of floral determinacy and organogenesis.

• L-Alanyl-L-Glutamine (B8228): Protocol and QC for Intestinal

  2026-06-23

  L-Alanyl-L-Glutamine (SKU B8228) addresses the challenge of glutamine instability in cell culture and in vivo research, providing reliable support for intestinal mucosa protection and barrier function enhancement. It is best suited for workflows requiring high solubility, antioxidant system support, and controlled nutrient delivery; it should not be used where DMSO or ethanol solubility is required or in protocols needing long-term aqueous solution storage.

• SM-102: Mechanistic Insights and Predictive Modeling for mRN

  2026-06-22

  Discover the advanced role of SM-102 in mRNA vaccine delivery, with a focus on mechanistic understanding and predictive modeling. This article presents deep scientific analysis and practical workflows, setting it apart from existing guides.

• SM-102 in mRNA Delivery: Protocol Optimization & Bladder Can

  2026-06-22

  SM-102 enables efficient, reproducible mRNA delivery via lipid nanoparticles, now validated in localized bladder cancer therapy. This article details stepwise workflows, troubleshooting strategies, and data-driven protocol enhancements using SM-102 from APExBIO.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Oncol

  2026-06-21

  Carboplatin stands out as a platinum-based DNA synthesis inhibitor pivotal to preclinical oncology workflows, offering robust, reproducible cytotoxicity in both ovarian and lung cancer models. This guide delivers protocol-driven insights, advanced troubleshooting, and data-backed optimization strategies to maximize Carboplatin’s translational impact.

• Ibuprofen in Cancer Research: Protocols, Applications & Trou

  2026-06-20

  Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) is revolutionizing colon cancer research by acting as both a dual COX inhibitor and a potent anti-proliferative agent. This guide delivers practical protocols, advanced use-cases, and troubleshooting strategies to maximize experimental reproducibility with APExBIO’s Ibuprofen.

• Malate as a Metabolic Modulator: Advanced Insights for TCA C

  2026-06-19

  Explore how malate ((S)-2-hydroxysuccinic acid) serves as a metabolic modulator in TCA cycle research, with a focus on immune-metabolic crosstalk and post-translational regulation revealed by recent cancer studies. This article delivers advanced mechanistic analysis and practical guidance for mitochondrial and immunometabolic assay design.

• Intravesical p21 mRNA–LNPs for Localized Bladder Cancer Ther

  2026-06-19

  This study demonstrates that intravesical delivery of p21 mRNA encapsulated in lipid nanoparticles (LNPs) effectively restores tumor suppressor function in bladder cancer models, markedly inhibiting tumor growth with minimal systemic exposure. The findings highlight a clinically viable approach for localized mRNA therapy and illustrate the pivotal role of optimized LNP systems in advancing targeted cancer therapeutics.

• NIR-Triggered Co-SAE Drives Multimodal ROS Phototherapy in C

  2026-06-18

  This study introduces a near-infrared (NIR) activated cobalt single-atom enzyme (Co-SAE) anchored on hollow N-doped carbon spheres, enabling synergistic photodynamic, photocatalytic, and photothermal therapy for head and neck cancer. The approach achieves robust amplification of highly reactive oxygen species (hROS) and mild hyperthermia, demonstrating enhanced tumor ablation with minimized collateral damage.

• DMG-PEG2000-NH2: Elevating Liposomal Drug Delivery Workflows

  2026-06-18

  DMG-PEG2000-NH2 is the versatile NH2-PEG derivative driving next-gen lipid nanoparticle and liposomal platforms for siRNA and protein delivery. This guide details applied workflows, troubleshooting, and unique insights from recent functionalized sulfonamide research—revealing how to maximize efficacy and reproducibility in advanced drug delivery.

16612 records 1/1108 page Next 12345 下5页 Last page